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The  identification  of cross-reactions  between  related  but  distinct  antigens 
during  anamnestic  responses  led  to  the  concept  of  "original  antigenic  sin" 
(1-3). Such cross-reactivity noted first for antibodies to different influenza virus 
strains was also observed for antibodies  to the haptens dinitrophenyl  (DNP) 1 
and  trinitrophenyl  (TNP)  (4),  and  to  sulfanilate-metanilate  haptenic  groups 
(5). 
In the system employing two strains of influenza virus as cross-reactlng antigens, 
the phenomenon was interpreted as a restricted anamnestic response to the primary 
antigen mediated by a trapping mechanism deflecting antigen from one kind of cell  to 
another  (3).  Chronologically analyzed, this process involved an early production of 
cross-reactive secondary response antibody followed by the primary response to the 
boosting antigen (3). 
Antibodies stimulated by either DNP or TNP protein conjugates had a high degree 
of immunological specificity. The anamnestic recall phenomenon in this system was 
explained as a process of degeneracy of the immune response reflected by high affinity 
antibodies with low specificities  (4). 
The serological  group specificity of streptococci results from distinct polysaccharide 
moieties characteristic for every group of streptococci (6, 7). For example, the group 
specific polysaccharides of A  (A-CHO) and A-variant (Av-CHO) streptococci share a 
branched  backbone of rhamnose.  They differ,  however, by the  terminal  N-acetyl- 
glucosaminide residues in Group A  streptococci linked fll  ~  3 glycosidically to the 
rhamnose side chains. This hexosamine moiety confers serological specificity to the 
Group A carbohydrate (6, 7). The A-variant polysaccharide, composed predominantly 
of rhamnose, has its cross-reactive serological  representation in di- and trisaccharides 
of rhamnose of unknown linkage (6, 7). 
Since antibodies  of restricted  electrophoretic mobility are inducible  against 
both  the  streptococcal  Groups  A  and  A-variant  polysaccharide  (8,  9),  the 
a Abbreviations used in this paper: A-CHO, streptococcal Group A polysaccharides; A-CHO 
tyr 125I and A-CHO tyr 131I, streptococcal Group A polysaccharides tyraminated  and either 
1251 or 131I labeled; Av-CHO, streptococcal  Group A-variant  polysaccharide; Av-CHO tyr 
125I and Av-CHO tyr 131I, streptococcal Group A-variant  polysaccharide tyraminated  and 
either 1251 or 181I labeled; DNP, dinitrophenyl; DNP- and TNP-BGG, dinitro- and trinitro- 
phenylated, respectively, bovine gamma globulin; IEF, isoelectric focusing; 1  ° immunization, 
primary immunization; 2  ° immunization, secondary immunization; TNP, trinitrophenyl. 
THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  •  VOLUME  138,  1973  1533 1534  ORIGINAL  ANTIGENIC  SIN 
system  lends  itself  for  reinvestigation  of  the  phenomenon  original  antigenic 
sin.  The  antibodies  induced  by  either  antigen  were compared  on  the  basis  of 
binding  specificity, molecular  restriction,  and  isoelectric focusing  (IEF)  char- 
acteristics documented  by comparative IEF  in analytical polyacrylamide gels. 
Materials and Methods 
Animals and immunization.--BALB/cJ  mice were used throughout  this work since they 
were known to produce high levels of restricted antibodies to the streptococcal Group A antigen 
(9-11).  They received a primary course of immunizations with Group A streptococcal vaccine 
(Group A streptococci, strain J17A4), hence referred to as course A, and 5-9 mo later a pri- 
mary course of injections with two strains of Group A-variant streptococcal vaccine (Group 
A variant streptococci, strain A486 var. M- and strain K43 vat.); all strains were kindly sup- 
pUed by Dr. R.  C. Lancefield, The Rockefeller University, New York.  This course will be 
referred to as course Av and course Av' respectively. Each immunization course was given 
intraperitoneally for a 4-wk period (10, 11). Another group of mice was, after a primary course 
A vaccination, challenged secondarily with Type III pneumocoecal vaccines (12). Antisera 
were obtained 5 days after the last injection and again several days later. 
Two control groups of mice received either a primary (course  A1 °) and secondary (course 
A2  °) immunization with Group A vaccine or a similar immunization with Group A-variant 
vaccine (course Avl  ° and 2°). Anfisera were obtained as above. 
Quantitation of the Immune Response.--Antibody levels were estimated by the amount of 
Ig absorbed  with homologous streptococcal cells measured  by a  combination of microzone 
electrophoresis and protein determination (10). A modified Farr assay (13) was used for direct 
quantitation employing tyraminated 125I labeled Groups A  (A-CHO tyr 125I) and A-variant 
(Av-CHO 125i) polysaecharides (11) obtained by the hot formamide extraction of streptococcal 
cell walls (14). 
Isoele~tric Focusing.--IEF was carried out by the method of Awdeh et al. (15). This tech- 
nique is a fast and convenient assay to determine the quality of specific antibodies in immune 
sara with regard to their degree of heterogeneity if combined with an antigen-binding assay. 
In this case,  lSlI-labeled tyraminated polysaccharide antigen (A-CHO tyr 131I and Av-CHO 
tyr 131I) was used to develop the patterns  (11). The technique also allows inhibition of the 
specific Group A reaction by preincubation with 5% N-acetyl-glucosamine solution which will 
compete for the antibody-combining sites with the radioactively labeled group carbohydrate 
added subsequently. 
In the sets of experiments shown here, identical amounts (e.g., 10/zl) of course A and course 
Av or Av' antisera from individual mice were focused in juxtapositions and reacted either with 
A-CHO tyr 131I or Av-CHO tyr  131I (10 #Ci per plate,  time of exposure 23  h).  Although 
qualitative,  this  procedure  permitted  direct comparison  of the  relative amounts  of cross- 
stimulated and/or cross-reactive monoclonal and multiclonal antibody populations. 
RESULTS 
Immunization  of BALB/cJ  mice with  either  Groups A  or Av streptococcal 
vaccine for the induction  of  1 ° and  2 ° immune  responses  associated with high 
levels of  restricted  antipolysaccharide  antibodies  leads  basically  to  a  similar 
observation  as  described  for  the  rabbit  (8,  9).  When  Av' vaccines were  used 
as antigens the response, although highly restricted for the variant antigen, was 
usually  lower  in  quantitative  terms  than  after  Av-vaccine  immunizations. 
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of molecularly restricted  antibodies  already identified  after 1  ° immunization. 
Two representative examples were depicted (Fig. 1). The identical IEF patterns 
of monoclonal antibodies raised in an individual mouse, e.g., clone products in 
course Avl ° and 2 ° antisera with IEF points  (pI) of pH 6.7-7.2,  must be re- 
garded as evidence for the expression of identical antibody molecules at different 
times  of immunization.  Preboost  antisera  are  generally devoid of significant 
levels of these monoclonal antibodies. If, in rare cases, they are demonstrable, 
they are present in levels at least  10X  lower.  Support for the interpretation 
that identical clones are triggered during both immunizations also comes from 
FIG. 1. Analytical IEF patterns of the 1  ° and 2 ° group A-CHO-specific antiserum of mouse 
X  developed with the A-CHO tyr 1311 and of the 1  ° and 2 ° group Av-CHO-specific antiserum 
of mouse XI developed with the Av-CHO tyr 131i. Identical monoclonal antibodies dominated 
in either situation as is indicated by --*. 
the rabbit model, where an individual  rabbits monoclonal antibody following 
both 1  ° and 2 ° immunization was indistinguishable by IEF and also carried the 
same idiotypic specificity (16). 
The notion of this control experiment is fundamental for the interpretation 
of  IEF  patterns  developed  with  mouse  antibodies  raised  by  immunization 
course A followed by course Av or course Av'. Such data are depicted in  Figs. 
2-6. 
Mouse sera I-IX (Figs. 2-6) are representative for 40 mice doubly immunized 
first with Group A vaccines and then with Groups Av (sera I-VII) or Av  p (sera 
VIII and  IX)  vaccines. All  nine  mice shown  here responded with  restricted 
antibodies to the A-CHO (patterns I-A to IX-A) (Figs. 2, 6), and subsequently 
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FIG.  2.  FIG. 3. 
FIG. 2. Analytical IEF patterns of 10/zl of mouse anfisera I-VII. These mice had received 
a  1  ° immunization course with group A streptococcal vaccines (A) and a  2 ° course with group 
Av streptococcal vaccines (Av). The patterns were developed with A-CHO tyr 1311 and exposed 
to the X-ray film for 23 h. 
FIG. 3. Analytical IEF  patterns of 10/zl of mouse antisera I-VII as in Fig.  2. Before the 
addition of A-CHO tyr 1311 the gels were exposed to 5% N-acetyl-glucosamlne. Exposure time 
to the X-ray film was 23 h. 
FIG.  4.  FIO.  5. 
FIO. 4. Analytical IEF patterns of 10/zl of mouse anfisera I-VII as in Fig. 2. The patterns 
were developed with Av-CHO tyr 131I and exposed to the X-ray film for 23 h. 
FIG.  5. Analytical IEF  patterns of 10 #l of mouse antisera I-VII  as in Fig.  2.  Before the 
addition of Av-CHO 131I, the gels were exposed to 5% N-acetyl-glucosamine. Exposure time 
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Av'  mice  expressed  defined  monoclonal  antibodies  to  the  variant  antigen. 
Individual mouse antisera  differed by both the degree of restriction  and  the 
number of stimulated monoclonal antibodies dominating the diffuse background 
of polysaccharide-specific antibodies. 
Comparison of the course A and course Av as well  as Av' antisera obtained 
from individual mice (Fig. 2, 6) revealed monoclonal A-CHO-specific antibodies 
(represented by a  three- to four-band pattern mostly) which were continuous 
into the course Av and course Av  p antisera (I, II, III, VI-IX). The intensity 
F~6. 6. Analytical IEF patterns of 15 #1 of mouse anfisera VIII and IX. These mice had 
received a  1  ° immunization with Group A streptococcal vaccine (A) and a 2  ° course with 
group Av' streptococcal  vaccine (Av'). A preboosting bleed (p) was included for comparison 
which contained  practically  no detectable A-CHO  antibody. The patterns were developed  with 
A-CHO tyr 131I and exposed to the X-ray film for 10 h. 
of banding with labeled A-CHO was usually less strong in the course Av  and 
Av' antisera. Since identical amounts of antisera were  applied,  this was taken 
as  an  indication  that  generally clones were  stimulated  less  intensely by  the 
heterologous antigen.  The very marked  A-CHO  specific  clone  of  antiserum 
III-A (pI 6.4-6.7), however, is equally prominent in the course Av antiserum. 
In antiserum II-Av two clones (pI 7.5-8.2, Fig. 2)  and antiserum IX-Av' two 
to three A-CHO-specific clones (pI 6.5-7.4, Fig. 6)  appeared to be stimulated 
to an even higher production than in the homologous antisera II-A, and IX-A, 
respectively. 
In general,  boosting with the closely related but distinct Av or Av  ~ strep- 
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to high levels already during 1  ° immunization with the homologous antigen. A 
somewhat  different  situation  was  observed in  antiserum  V-Av  whose  com- 
panion  course A  antiserum was  rather  complex in  terms of A-CHO-binding 
specificities. Antiserum IV-Av represents an  example of those five out of 30 
mice  where  no  stimulation  of  group  A-CHO-specific  clones  occurred  upon 
immunization with Av-variant vaccines. 
Incubation of a companion IEF gel with 5 % N-acetyl-glucosamine (Fig. 3) 
(this  hexosamine  is  inhibitory  for  the  Group  A-specific precipitin  reaction 
[6, 7]) for 20 rain at 37°C before the addition of the labeled A-CHO rendered 
all but one distinct clone (antiserum VII-Av, pI 6.8-7.1), covered in an intense 
smear of the A-CHO specific antiserum, specifically inhibitable.  Under condi- 
tions depicted here, antisera IV-A and III-Av best demonstrated the degree of 
specificity (compare clones  at  pI  7.7-8.4,  6.4-6.7  and  7.4-8.5,  respectively). 
However, if only 1 ~1 of antisera I-VII were subjected to the same conditions, 
all  strongly expressd clones in  the experiment of Fig.  3  diminished substan- 
tially, indicating an excess antibody in 10 #1 of antiserum over the inhibiting 
hapten  concentration.  Thus,  free  antibody  was  available  to  bind  labeled 
A-CHO. 
Testing for the occurrence of restricted variant-specific antibodies in  both 
course Av and course Av' antisera was performed in  a parallel set of experi- 
ments. Thus, if 10 ~1 of each course A and course Av, respectively, Av' anti- 
serum were developed after IEF with Av-CHO tyr ~alI, which was shown to 
consist almost  exclusively of rhamnose  (6,  7),  patterns were obtained as de- 
picted for Av-antisera in  Fig.  4.  Clear-cut monoclonal antibody populations 
were stimulated  which  were absent in  the course A  antisera,  however. This 
observation  also  held  for  the  Av'  antisera  where  only after the  course Av  ~ 
homogeneous antibodies  binding  specifically  to  the  radiolabeled  Av-antigen 
were identified which were absent in the course A antisera of these mice. 
The degree of specificity for the Av-CHO is exclusive for all  strongly ex- 
pressed antibody clones (antisera II-Av and VI-Av), as well as Av' antibody 
clones not shown here. Some slightly cross-reactive and very minor clones were 
only present in the weak antisera I-Av and I-A as well as VII-Av and VII-A 
developed clearly only after doubling or tripling of the exposure time. As  a 
result  of  this  variant  polysaccharide  specificity,  5%  N-acetyl-glucosamine 
added before the addition of Av-CHO tyr lalI was ineffective as inhibitor (Fig. 5). 
A  modified Farr assay  (13)  was  designed to quantitate  specific antibodies 
in course Av and Av' immune sera by binding to the isolated mI-labeled A- 
CHO and Av-CHO. The experiments generally revealed an excess of A-CHO 
specific antibodies over the Av-CHO-binding antibodies, corresponding to the 
qualitative data obtained by IEF. However, this was not the case for antisera 
IV-Av and V-Av. 
The strict  serological specificity for the  homologous group polysaccharide 
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Av antisera which employed excess of Group A  and Group Av streptococcal 
cells used as vaccines for immunization. Absorption with Group A streptococ- 
cal cells removed all but the Av-specific antibodies, and conversely absorption 
with Group Av streptococcal cells removed selectively the  Group Av-specific 
antibodies. 
In order to eliminate the possibility that  the  Group A-CHO-binding  anti- 
bodies  in  the  course Av-antisera  were  binding  to  the  N-acetyl-glucosamine 
moiety of the mucopeptide (antibodies directed to the sugar moieties of the 
mucopeptide  were  reported  [17]) and  that  renewed  stimulation  of  defined 
monoclonal A-CHO specific antibodies was due to such cross-reaction, 50 ~1 of 
antisera VIII-Av' and IX-Av' were absorbed with 3 mg each of 090R muco- 
peptide  2 for 60 min at room temperature and 12 h  at 4°C. The antiserum was 
recovered by centrifugation and  again focused on  two pH 5-10 gels,  one of 
which was  specifically stained with  the  radiolabeled A-CHO  and the second 
with radiolabeled Av-CHO. Since no absorption of the A-CHO-specific clones 
which were triggered during course A and again during course Av' immuniza- 
tion was achieved by the sugar moiety of the mucopeptide preparation, it was 
concluded that this part of the streptococcal cell wall did not cross-react to a 
significant degree with these particular monoclonal A-CHO antibodies.  From 
this result we would conclude furthermore that their restimulation during the 
course Av' immunization was mediated by some other mechanism rather than 
cross-reaction  via  a  possible  N-acetyl-glucosamine  determinant  shared  by 
gram-positive and gram-negative bacteria (17). 
To further support  this  interpretation,  10 mice received after a  course A 
immunization 3-7 mo later an intraperitoneal injection course with Type III 
pneumococcal  vaccine.  If  the  N-acetyl-glucosaminide  residue  of  the  sugar 
moiety in  the  mucopeptide of these bacteria was  cross-stimulating A-CHO- 
specific antibody clones revealed during the course A immunization, these were 
expected to be restimulated under these conditions. This was not the case. 
DISCUSSION 
In  the production of standard  antisera  to streptococcal Groups A  and A- 
variant, cross-reactions between these related but serologically distinct antigens 
may be encountered. Two explanations for such an event are at hand: (a) two 
antigens share common determinants which are recognized by the immunized 
animal, and (b) cross-reactivity is a function of cross-stimulation of two anti- 
body populations in the antiserum, one specific for one and the other for the 
related antigen. This is in essence the phenomenon of the anamnestic response 
as it was observed for various strains of influenza viruses (1-3), the DNP and 
TNP ligands (4),  sulfanilate-metanilate haptenic groups (5),  and some serum 
proteins (8-20). 
2 This preparation was derived  from the serological Group B  streptococcal strain O90R. 1540  ORIGINAL ANTIGENIC  SIN 
For the streptococcal Group polysaccharides A  and A variant, the case can 
be carried further.  Removal of the  terminal  N-acetyl-glucosaminide residues 
from the A-CHO by an N-acetyl-glucosaminidase changes the serological and 
chemical  properties  of  the  polysaccharide  into  those  of  a  typical  Av-CHO 
(6, 7). Thus, the situation for probing the phenomenon of original antigenic sin 
appears favorable if it could be shown that antibody populations triggered are 
of strict specificities for either antigen and not the result of a shared immuno- 
dominant determinant. 
This experimental system has an additional advantage in that homogeneous 
antibodies can be raised to both the A-CHO and the Av-CHO in rabbits (8, 9) 
and in mice (10,  11, 21,  22). Consequently, the phenomenon of the anamnestic 
response  could  be investigated  on  the  level  of  monoclonal  antibodies  with 
clearly defined IEF spectra. 
From the data presented here, it is apparent that the overwhelming quantity 
of antibody raised against either streptococcal antigen is of exquisite specificity. 
It appeared  that  the  major fraction  of the A-CHO-specific antibodies of re- 
stricted molecular properties was inhibited to bind the A-CHO tyr 131I by the 
addition of excess N-acetyl-glucosamine and thus directed to this determinant, 
which  is characteristic for Group A-specific antibodies  (6,  7).  Cross-reacting 
antibodies with  the Av-CHO were,  if present, close or below  detection  level 
even with the rather sensitive radioimmuno assay. This was taken as evidence 
for nonoverlapping immunodominant determinants, despite the fact that both 
polysaccharides share  a  backbone of rhamnose, presumably indistinguishable 
if the proper determinants are made available to react with the antibody or to 
stimulate its production by contact with the antigen-sensitive cell. 
With respect to this exclusive serological specificity, a similar conclusion was 
reached for DNP-BGG and TNP-BGG employed as cross-reacting ligands for 
cross-boosting.  In  those experiments  also,  a  virtually nonoverlapping  set  of 
antigen-sensitive cells was stimulated (4). 
The extraordinary degree of specificity and the lack of cross-reaction  was very clear 
for the monoclonal  antibodies in  the antisera obtained after immunization with A- 
variant and A-variant' vaccines as the boosting antigens.  The lack of cross-reactivity 
between the haptens m-aminobenzoic acid  and m-sulfanilic  acid at the level of the 
antibody-secreting cell was recently emphasized.  Nevertheless, the recall phenomenon 
could be induced in C57BL mice by successive immunizations with these haptens (23). 
In our experiments, precisely those plasma cell clones were restimulated  to yield a 
dominant secondary-type response  that had  dominated  the pattern in  the antisera 
raised with the primary immunogen, although the radioimmunoassay rendered them 
as noncross-reactive when isolated Av-CHO was used. Thus, they met all requirements 
to fulfil the recall phenomenon (3) which postulates that a noncross-reacting  antigen, 
lacking in this case precisely the immunodominant N-acetylated hexosamine~ provokes 
a response to an antigen experienced  previously by the individual.  In addition,  the 
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were highly and only selective for this antigen which is so totally mimiced by the 
A-CHO once devoid of the terminal N-acetylated hexosamine moiety (7). 
The  possibility  that  the  Av-CHO  antigen  may  possess  N-acetyl-glucosamine 
moieties  immunogenicaUy active and thus constituting A-CHO determinants, since 
revertants from the A486 var. strain to A-CHO-carrying bacteria were observed (24), 
seems unlikely for the following reason: immunization with strain K43 var. led to an 
identical  observation made with course A486-variant  antisera. Furthermore, growth 
of the bacteria was exclusively performed at 37°C at which temperature no revertants 
were observed  (24). Appropriate absorption studies  with the streptococcal Av-CHO 
cells used as vaccine and with mucopeptide which also contains N-acetyl-glucosamine, 
furthermore excluded this alternative. 
The typical secondary-type response cannot rest in a  qualitative change of 
the  antibodies  triggered:  they are  identical.  It must  rest  on  the  state  of 
memory and/or antibody-secreting cells developed by the  first  proliferative 
process to a particular level; restimulation  at this  level requires an alterna- 
tive  explanation to mere cross-reactivity with N-acetyl-glucosamine-contain- 
ing determinants. 
The argument  was raised  that  original  antigenic  sin  was  the  example  of 
degeneracy in the immune response; a process by which specificity is sacrificed 
with low affinity antibodies to gain antibodies of high affinity associated with 
greater cross-reactivity which are also more heterogeneous (4). Clearly, in the 
system of anamnestic  response to streptococcal polysaccharide antigens,  this 
is  not  the  case.  The  monoclonal  populations  of  antibody  raised  by  the 
anamnestic response are highly specific for the homologous antigens,  and the 
IEF patterns of the immune sera are reduced in complexity rather than in- 
creased. 
These data then furnish evidence for the view that the secondary response, 
resulting  from  injections  with  nonhomologous  antigen  (3)  is  specific  and 
clonally selective for the primary homologous antigen and this occurs as effec- 
tively and sometimes even better than the response to the primary course of 
immunization.  The  underlying mechanism  may simply  be  immunogenic  re- 
activation of persisting antigen (25). This possibility, however, appears unlikely 
because a secondary immunization course with the serologically unrelated Type 
III pneumococcal vaccine was not stimulating for the A-CHO-specific mono- 
clonal antibodies so extensively produced during the primary course A. 
An  alternative  explanation appears  to  be  more attractive:  in  the  system 
presented here where extensive in vitro cross-reactions are lacking, the situation 
is reduced to clonal dominance and persistence at the level of some kind of 
memory cells which are then reactivated for the anamnestic response. Clearly 
this has to do with the number and possibly also the efficiency of either the 
antigen-sensitive  and/or  the  antibody-secreting  cells  of  a  particular  clone. 
Efficiency in our view would simply be an expression of the difference in thresh- 
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synthesis and secretion as compared to the primary stimulus, and is thus prob- 
ably a  function of a  particular property of the membrane expressing specific 
Ig  receptors. Low  affinities recognizing the  common rhanmose  backbone of 
both antigens not measurable with our conventional antigen-binding techniques 
might  still reflect the relatedness of the antigens.  This image of the original 
antigen in which  the  terminal N-acetylated glucosamine is not  only the de- 
terminant but rather the immunodominant group, might suffice as the starting- 
off signal  for synthesis and secretion of antibody specifically combining with 
the /31  --* 3  N-acetyl-glucosamine determinants.  Only in this sense would we 
interpret  the  response as  deflected (3);  however, this  does not  apply to the 
quality of antibody still highly specific for the original antigen contact. 
Recently Ivanyi ascribed  the mandatory role in  the recall  phenomenon to the 
thymus-derived cell (26). Although both thymus- and bone marrow-derived  cells are 
required for the induction of the Group A-CHO response in the immunologically virgin 
thymus cell reconstituted nude mouse (9-10),  in our opinion the phenomenon of the 
anamnestic response  depends  on the second, truly efferent level of the immune re- 
sponse: here the bone marrow-derived cells as the antibody-secreting cell may be the 
only target for the turn-on phenomenon due to a special arrangement and/or flexibility 
of  the  antibodies  functioning  as  receptors.  In  the  streptococcal system the recall 
phenomenon is therefore to be formulated as a reflection of cross-stimulation  rather 
than cross-reaction as a typical secondary response of persisting  antibody cell clones. 
SUMMARY 
Immunization of BALB/c mice with Group A  streptococcal vaccines leads 
to the induction of high levels of monoclonal antibody populations. Subsequent 
immunization of these mice with  Group A-variant streptococcal vaccines in- 
duces a significant level of monoclonal antibody of A-variant antigen specificity 
revealed by labeled group A-variant polysaccharide. During  these course Av 
and Av' immunizations, the monoclonal Group A-specific antibodies were also 
restimulated to levels usually higher than the variant-specific antibodies. With 
two  exceptions,  these  homogeneous  antibody  populations  were  not  cross- 
reactive in vitro with the related antigen. Such cross-stimulation of monoclonal 
antibodies was interpreted as a function of particular membrane properties of 
the  Ig  receptor-bearing memory  cells  which,  for  restimulation,  would  only 
require the structurally closely related antigen which serves as a backbone to 
the original antigen, and not necessarily the exact fit of the homologous immuno- 
dominant group. 
The authors are indebted  to Doctors J.  R. Little  and S.  E.  Read  for their critical review 
of the manuscript. 
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